Alan Meyer, CEO Ocularis Pharma
“We can measure contrast sensitivity without introducing bias.”
Ocularis Pharma CEO Alan Meyer talks about using the Smart System for clinical trials.
Ocularis Pharma CEO Alan Meyer talks about using the Smart System for clinical trials.
Learn More about our award winning products
Learn More